Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

Summary

The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and treatment, clarifying the pathogenesis, and providing scientific basis for the prevention and treatment are hot research topics in the study of cardiovascular and cerebrovascular diseases. This study intends to collect clinical data and biological specimen data of patients with cardiovascular and cerebrovascular diseases who meet the inclusion and exclusion criteria, and use multi-omics technology to deeply understand the pathogenic mechanisms of cardiovascular and cerebrovascular diseases and provide new ideas for specific and individualized treatment of patients with cardiovascular and cerebrovascular diseases, to construct early predictive prognostic models and provide a basis for effective treatment of clinical practice in patients with cardiovascular and cerebrovascular diseases.

Conditions

• Coronary Artery Disease
• Arrhythmias, Cardiac
• Heart Valve Diseases
• Aortic Dissection
• Heart Neoplasms
• Myocarditis
• Hypertension
• Cardiomyopathies
• Structural Heart Disease
• Ischemic Cerebrovascular Disease
• Hemorrhagic Cerebrovascular Disease
• Brain Neoplasms

Interventions

OTHER

Observational; No Interventions were given.

Observational; No Interventions were given.

Sponsors & Collaborators

• Xi'an Gaoxin Hospital

  collaborator OTHER

• First Affiliated Hospital of Chongqing Medical University

  collaborator OTHER

• General Hospital of Ningxia Medical University

  collaborator OTHER

• Second Affiliated Hospital of Nanchang University

  collaborator OTHER

• First Affiliated Hospital Xi'an Jiaotong University

  lead OTHER

Principal Investigators

• Gouliang Li · First Affiliated Hospital Xi'an Jiaotong University

• Yang Yan · First Affiliated Hospital of Xian Jiaotong University

Eligibility

Min Age

3 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-12-05

Primary Completion

2028-06-30

Completion

2028-12-31

Countries

• China

Study Locations